Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutationsBAYRAKTAR, Soley; GUTIERREZ-BARRERA, Angelica M; HORTOBAGYI, Gabriel N et al.Breast cancer research and treatment. 2011, Vol 130, Num 1, pp 145-153, issn 0167-6806, 9 p.Article

Management of Local-Regional Recurrence following Immediate Breast Reconstruction in Patients with Early Breast Cancer Treated without Postmastectomy RadiotherapySHARMA, Ranjna; ROURKE, Loren L; KUERER, Henry M et al.Plastic and reconstructive surgery (1963). 2011, Vol 127, Num 5, pp 1763-1772, issn 0032-1052, 10 p.Article

Perception of Screening and Risk Reduction Surgeries in Patients Tested for a BRCA Deleterious MutationLITTON, Jennifer K; WESTIN, Shannon N; ARUN, Banu K et al.Cancer. 2009, Vol 115, Num 8, pp 1598-1604, issn 0008-543X, 7 p.Article

Incidence of Brain Metastases as a First Site of Recurrence Among Women With Triple Receptor―Negative Breast CancerDAWOOD, Shaheenah; XIUDONG LEI; LITTON, Jennifer K et al.Cancer. 2012, Vol 118, Num 19, pp 4652-4659, issn 0008-543X, 8 p.Article

Wound Complications from Surgery in Pregnancy-Associated Breast Cancer (PABC)DOMINICI, Laura S; KUERER, Henry M; LITTON, Jennifer K et al.Breast disease. 2010, Vol 31, Num 1, pp 1-5, issn 0888-6008, 5 p.Article

Multifocal breast cancer in women ≤35 years oldLITTON, Jennifer K; ERALP, Yesim; GONZALEZ-ANGULO, Ana M et al.Cancer. 2007, Vol 110, Num 7, pp 1445-1450, issn 0008-543X, 6 p.Article

Earlier Age of Onset of BRCA Mutation-Related Cancers in Subsequent GenerationsLITTON, Jennifer K; READY, Kaylene; ARUN, Banu K et al.Cancer. 2012, Vol 118, Num 2, pp 321-325, issn 0008-543X, 5 p.Article

Effectiveness of Alternating Mammography and Magnetic Resonance Imaging for Screening Women With Deleterious BRCA Mutations at High Risk of Breast CancerLE-PETROSS, Huong T; WHITMAN, Gary J; ATCHLEY, Deanne P et al.Cancer. 2011, Vol 117, Num 17, pp 3900-3907, issn 0008-543X, 8 p.Article

Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast CancerGONZALEZ-ANGULO, Ana M; TIMMS, Kirsten M; HORTOBAGYI, Gabriel N et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 1082-1089, issn 1078-0432, 8 p.Article

Utility of Oncotype DX Risk Estimates in Clinically Intermediate Risk Hormone Receptor-Positive, HER2-Normal, Grade II, Lymph Node-Negative Breast CancersKELLY, Catherine M; KRISHNAMURTHY, Savitri; BIANCHINI, Giampaolo et al.Cancer. 2010, Vol 116, Num 22, pp 5161-5167, issn 0008-543X, 7 p.Article

Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body massKUERER, Henry M; LARI, Sara A; LITTON, Jennifer K et al.Breast cancer research and treatment. 2012, Vol 133, Num 3, pp 1131-1141, issn 0167-6806, 11 p.Article

Early Onset HER2-Positive Breast Cancer Is Associated With Germline TP53 MutationsMELHEM-BERTRANDT, Amal; BOJADZIEVA, Jasmina; ARUN, Banu K et al.Cancer. 2012, Vol 118, Num 4, pp 908-913, issn 0008-543X, 6 p.Article

Effect of Metformin on Survival Outcomes In Diabetic Patients With Triple Receptor-Negative Breast CancerBAYRAKTAR, Soley; HERNADEZ-AYA, Leonel F; XIUDONG LEI et al.Cancer. 2012, Vol 118, Num 5, pp 1202-1211, issn 0008-543X, 10 p.Article

The Impact of Pregnancy on Breast Cancer Outcomes in Women <35 YearsBEADLE, Beth M; WOODWARD, Wendy A; MIDDLETON, Lavinia P et al.Cancer. 2009, Vol 115, Num 6, pp 1174-1184, issn 0008-543X, 11 p.Article

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2-Positive, Node-Negative Tumors 1 cm or SmallerGONZALEZ-ANGULO, Ana M; LITTON, Jennifer K; LARSIMONT, Denis et al.Journal of clinical oncology. 2009, Vol 27, Num 34, pp 5700-5706, issn 0732-183X, 7 p.Article

Relationship Between Obesity and Pathologic Response to Neoadjuvant Chemotherapy Among Women With Operable Breast CancerLITTON, Jennifer K; GONZALEZ-ANGULO, Ana M; WARNEKE, Carla L et al.Journal of clinical oncology. 2008, Vol 26, Num 25, pp 4072-4077, issn 0732-183X, 6 p.Article